The trial met its primary endpoint with a hazard ratio of 0.75, indicating a significant reduction in disease progression ...

A positive top-line readout from a phase 3 trial has emboldened Incyte to seek the FDA’s blessing for the company’s Monjuvi ...

Four symptoms may indicate a possible relapse of diffuse large B-cell lymphoma. Learn more about them and when to contact a doctor. A relapse of diffuse large B-cell lymphoma can cause a variety of ...

Fan pattern A, so-called classical B-cell-rich nodular pattern: Clusters of single LP cells are embedded within enlarged follicles/nodules predominantly composed of small B-cells. Reactive T-cells are ...

Stage 4 diffuse large B-cell lymphoma (DLBCL) is a rapidly growing lymphoma affecting at least one other organ outside the lymphatic system. Cancer is the unusual growth and spread of cells within the ...